应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KVUE Kenvue Inc
休市中 08-28 16:00:00 EDT
19.17
-0.03
-0.16%
盘后
19.17
+0.00
0.00%
19:46 EDT
最高
19.39
最低
19.13
成交量
1,189万
今开
19.26
昨收
19.20
日振幅
1.35%
总市值
367.30亿
流通市值
362.78亿
总股本
19.16亿
成交额
2.28亿
换手率
0.63%
流通股本
18.92亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Essity斥资2.84亿美元收购巴西女性护理业务
投资观察 · 08-20
Essity斥资2.84亿美元收购巴西女性护理业务
Zyrtec®推出全新无药物过敏原防护喷雾,开创日常*过敏原主动防御新纪元
美股速递 · 08-18
Zyrtec®推出全新无药物过敏原防护喷雾,开创日常*过敏原主动防御新纪元
南非竞争法庭:金佰利与Kenvue Inc交易附条件获批
美股速递 · 08-15
南非竞争法庭:金佰利与Kenvue Inc交易附条件获批
异动解读 | 季度业绩略低于预期,Kenvue盘前大跌8.08%
异动解读 · 08-06
异动解读 | 季度业绩略低于预期,Kenvue盘前大跌8.08%
Kenvue 宣布:FDA 授予泰诺新非处方配方三年市场独占权
投资观察 · 07-25
Kenvue 宣布:FDA 授予泰诺新非处方配方三年市场独占权
FDA批准泰诺®与萘普生复方制剂:首款非处方对乙酰氨基酚(650毫克)与萘普生钠(220毫克)固定剂量组合
美股速递 · 07-25
FDA批准泰诺®与萘普生复方制剂:首款非处方对乙酰氨基酚(650毫克)与萘普生钠(220毫克)固定剂量组合
美国FDA批准首款对乙酰氨基酚/萘普生非处方组合产品——泰诺联用萘普生,提供12小时镇痛效果
美股速递 · 07-24
美国FDA批准首款对乙酰氨基酚/萘普生非处方组合产品——泰诺联用萘普生,提供12小时镇痛效果
泰诺裁决不影响金佰利收购案,Kenvue Inc 风险可控
投资观察 · 07-14
泰诺裁决不影响金佰利收购案,Kenvue Inc 风险可控
南非竞争委员会建议:附条件批准金佰利与Kenvue Inc的交易
美股速递 · 06-02
南非竞争委员会建议:附条件批准金佰利与Kenvue Inc的交易
Greyparrot与Kenvue携手,借AI材料回收智能加速循环包装进程
美股速递 · 05-20
Greyparrot与Kenvue携手,借AI材料回收智能加速循环包装进程
Kenvue在SEC文件中指出:中东冲突导致局势动态变化,预计宏观经济环境将持续波动
美股速递 · 05-07
Kenvue在SEC文件中指出:中东冲突导致局势动态变化,预计宏观经济环境将持续波动
Kenvue Inc因与金佰利交易未决 暂停发布业绩前瞻指引
美股速递 · 05-07
Kenvue Inc因与金佰利交易未决 暂停发布业绩前瞻指引
加拿大投资银行集团:维持Kenvue(KVUE.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至29.00美元。
金融界 · 2025-03-06
加拿大投资银行集团:维持Kenvue(KVUE.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至29.00美元。
瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由23.00美元调整至21.00美元。
金融界 · 2025-02-08
瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由23.00美元调整至21.00美元。
肯维公司第四季度调整后每股收益 $0.26 符合预期,销售额 $36.6 亿低于 $37.7 亿预期
财报速递 · 2025-02-06
肯维公司第四季度调整后每股收益 $0.26 符合预期,销售额 $36.6 亿低于 $37.7 亿预期
瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由24.00美元调整至23.00美元。
金融界 · 2025-01-17
瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由24.00美元调整至23.00美元。
花旗:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由25.00美元调整至21.00美元。
金融界 · 2025-01-16
花旗:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由25.00美元调整至21.00美元。
Piper Sandler:上调Kenvue(KVUE.US)评级,由中性调整至增持评级, 目标价由21.00美元调整至26.00美元。
金融界 · 2025-01-07
Piper Sandler:上调Kenvue(KVUE.US)评级,由中性调整至增持评级, 目标价由21.00美元调整至26.00美元。
顶级亿万富豪投资者的五笔股票买卖
福布斯中文网 · 2024-12-12
顶级亿万富豪投资者的五笔股票买卖
Kenvue Inc.盘中异动 急速跳水5.00%
市场透视 · 2024-12-05
Kenvue Inc.盘中异动 急速跳水5.00%
加载更多
公司概况
公司名称:
Kenvue Inc
所属市场:
NYSE
上市日期:
--
主营业务:
Kenvue Inc.于2022年2月23日在特拉华州成立。该公司是全球最大的纯消费者健康公司。该公司寻求通过提供以消费者健康为中心的科学支持的创新产品、解决方案和体验,实现可持续的盈利增长。他们的业务遍及全球超过165个国家,并拥有超过135年的传统,在医疗保健和消费品的交叉点上处于全球领先地位。
发行价格:
--
{"stockData":{"symbol":"KVUE","market":"US","secType":"STK","nameCN":"Kenvue Inc","latestPrice":19.17,"timestamp":1787947200000,"preClose":19.2,"halted":0,"volume":11888632,"hourTrading":{"tag":"盘后","latestPrice":19.17,"preClose":19.17,"latestTime":"19:46 EDT","volume":43569,"amount":835213.4965,"timestamp":1787960785655,"change":0,"changeRate":0,"amplitude":0.00313},"delay":0,"changeRate":-0.0015624999999998743,"floatShares":1892411259,"shares":1916011651,"eps":0.849997,"marketStatus":"休市中","change":-0.03,"latestTime":"08-28 16:00:00 EDT","open":19.26,"high":19.39,"low":19.13,"amount":228266668.18228,"amplitude":0.013542,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.849997,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"listingDate":1683172800000,"exchange":"NYSE","adjPreClose":19.2,"dividendRate":0.043281,"preHourTrading":{"tag":"盘前","latestPrice":19.13,"preClose":19.2,"latestTime":"09:24 EDT","volume":351,"amount":6770.529909000001,"timestamp":1787923476267,"change":-0.07,"changeRate":-0.003646,"amplitude":0.010417},"postHourTrading":{"tag":"盘后","latestPrice":19.17,"preClose":19.17,"latestTime":"19:46 EDT","volume":43569,"amount":835213.4965,"timestamp":1787960785655,"change":0,"changeRate":0,"amplitude":0.00313},"volumeRatio":0.6587309104438777,"impliedVol":0.2064,"impliedVolPercentile":0.1036},"requestUrl":"/m/hq/s/KVUE","defaultTab":"news","newsList":[{"id":"1171291472","title":"Essity斥资2.84亿美元收购巴西女性护理业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1171291472","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171291472?lang=zh_cn&edition=full","pubTime":"2026-08-20 02:07","pubTimestamp":1787162822,"startTime":"0","endTime":"0","summary":"8月19日(路透社)—— Essity AB (publ) 宣布达成一项重要交易。该公司将以现金及无债务基础的方式,斥资2.84亿美元收购巴西女性护理业务。此次收购囊括了Carefree、Sempre Livre和o.b.等知名品牌,同时还包括位于巴西的相关生产设备。Essity此番动作,旨在从Kenvue手中接棒其在巴西的女性护理业务板块。这一战略举措,无疑将重塑巴西女性护理市场的竞争格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","GLAM","BK4183","KVUE","LU0310800379.SGD","BK4588","LU0029864427.USD","LU1267930813.SGD","LU0708994859.HKD","LU0128525929.USD","LU0889566641.SGD","RSPS","LU1267930573.SGD","IE00B3T34201.USD","BK4585","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133803831","title":"Zyrtec®推出全新无药物过敏原防护喷雾,开创日常*过敏原主动防御新纪元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133803831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133803831?lang=zh_cn&edition=full","pubTime":"2026-08-18 18:47","pubTimestamp":1787050069,"startTime":"0","endTime":"0","summary":"Zyrtec正式发布其革命性新品——无药物过敏原防护喷雾。这一创新产品,标志着过敏原防御领域迎来重大突破,为消费者提供了前所未有的日常*主动防护方案。Zyrtec此番布局,精准捕捉到了消费者对“预防胜于治疗”理念日益增长的需求。市场分析人士指出,该产品的上市,不仅丰富了Zyrtec自身的产品矩阵,更有可能重塑过敏防护市场的竞争格局。目前,该款过敏原防护喷雾已率先在指定零售渠道及线上平台开售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","KVUE","LU0708994859.HKD","BK4183","LU0792757196.USD","LU0128525929.USD","LU1267930813.SGD","LU1267930573.SGD","LU0310800379.SGD","RSPS","LU0029864427.USD","IE00BFXG1179.USD","BK4585","LU0889566641.SGD","IE00B3T34201.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145078019","title":"南非竞争法庭:金佰利与Kenvue Inc交易附条件获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1145078019","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145078019?lang=zh_cn&edition=full","pubTime":"2026-08-15 00:31","pubTimestamp":1786725070,"startTime":"0","endTime":"0","summary":"南非竞争法庭已正式批准金佰利(Kimberly-Clark)与Kenvue Inc之间的交易,但附加了若干条件。这一决定标志着双方并购进程中的关键节点,同时也为市场参与者带来了新的期待与考量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","LU0708994859.HKD","LU1267930573.SGD","LU2463526074.USD","BK4585","RSPS","BK4567","BK4018","LU0029864427.USD","IE00B3T34201.USD","IE00BFXG1179.USD","LU1267930813.SGD","LU1430594728.SGD","LU0792757196.USD","KVUE","LU0128525929.USD","BK4183","LU1585245621.USD","LU1571399168.USD","BK4588","LU0889566641.SGD","KMB","SG9999001440.SGD","LU0310800379.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100372965","title":"异动解读 | 季度业绩略低于预期,Kenvue盘前大跌8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100372965","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100372965?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:12","pubTimestamp":1786014729,"startTime":"0","endTime":"0","summary":"Kenvue Inc(KVUE)今日盘前股价大跌8.08%,引发市场关注。消息面上,公司公布的季度业绩略低于市场预期。数据显示,Kenvue第二季度净销售额为39.6亿美元,略低于分析师预期的39.7亿美元;经调整后每股收益为31美分,同样低于分析师预期的32美分。业绩未达预期成为股价承压的主要原因。此外,公司表示与金佰利·克拉克(KMB)的交易预计将于第四季度完成。截至上一交易日收盘,KVUE今年以来累计上涨约14%。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106583056","title":"Kenvue 宣布:FDA 授予泰诺新非处方配方三年市场独占权","url":"https://stock-news.laohu8.com/highlight/detail?id=1106583056","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106583056?lang=zh_cn&edition=full","pubTime":"2026-07-25 02:17","pubTimestamp":1784917050,"startTime":"0","endTime":"0","summary":"7月24日——Kenvue 公司披露,美国食品药品监督管理局已正式批准泰诺与萘普生的复方制剂。这是市面上首款,也是唯一一款含有对乙酰氨基酚和萘普生钠的非处方固定剂量组合产品。不仅如此,FDA还授予了该新配方长达三年的市场独占权。这一举措,无疑为Kenvue在非处方止痛药领域的布局提供了坚实的护城河。据Kenvue方面透露,这款名为“泰诺与萘普生”的新品很快将在美国各大主要零售商上架销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU1267930813.SGD","GLAM","IE00B3T34201.USD","LU0310800379.SGD","LU0029864427.USD","LU0792757196.USD","LU1267930573.SGD","IE00BFXG1179.USD","RSPS","BK4588","LU0708994859.HKD","KVUE","BK4585","LU0889566641.SGD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128949873","title":"FDA批准泰诺®与萘普生复方制剂:首款非处方对乙酰氨基酚(650毫克)与萘普生钠(220毫克)固定剂量组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1128949873","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128949873?lang=zh_cn&edition=full","pubTime":"2026-07-25 02:01","pubTimestamp":1784916077,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)已正式批准泰诺®与萘普生复方制剂上市。这款产品是首款且唯一一款非处方固定剂量组合药物,其成分为对乙酰氨基酚(650毫克)与萘普生钠(220毫克)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889566641.SGD","LU0310800379.SGD","IE00B3T34201.USD","LU0128525929.USD","GLAM","KVUE","RSPS","BK4585","IE00BFXG1179.USD","LU0708994859.HKD","LU0029864427.USD","BK4183","LU0792757196.USD","LU1267930573.SGD","BK4588","LU1267930813.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164500582","title":"美国FDA批准首款对乙酰氨基酚/萘普生非处方组合产品——泰诺联用萘普生,提供12小时镇痛效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1164500582","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164500582?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:48","pubTimestamp":1784904499,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)近日正式批准了泰诺(Tylenol)与萘普生(Naproxen)的联合用药方案。这是首款非处方(OTC)复方制剂,将对乙酰氨基酚(Acetaminophen)与萘普生(Naproxen)合二为一,专为缓解疼痛而设计,其药效可长达12小时。这一创新组合,有望为饱受疼痛困扰的患者提供更持久、更便捷的镇痛选择,无需频繁服药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPS","LU0128525929.USD","LU0792757196.USD","KVUE","LU0310800379.SGD","LU1267930573.SGD","LU0708994859.HKD","IE00B3T34201.USD","BK4588","BK4585","IE00BFXG1179.USD","LU0029864427.USD","LU0889566641.SGD","LU1267930813.SGD","GLAM","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165988170","title":"泰诺裁决不影响金佰利收购案,Kenvue Inc 风险可控","url":"https://stock-news.laohu8.com/highlight/detail?id=1165988170","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165988170?lang=zh_cn&edition=full","pubTime":"2026-07-14 02:52","pubTimestamp":1783968758,"startTime":"0","endTime":"0","summary":"尽管一项针对 Kenvue Inc 的诉讼裁决允许继续调查泰诺与神经发育障碍之间的潜在关联,这对公司而言无疑是个负面消息,但分析师认为,这不太可能危及金佰利对其的收购计划。原因在于,若诉讼进一步推进并导致对 Kenvue Inc 不利的结果,公司可能面临重大的潜在负债风险。市场反应方面,Kenvue Inc 股价下跌1.8%,金佰利股价则下跌2.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","LU1571399168.USD","LU1430594728.SGD","SG9999001440.SGD","KMB","IE00BFXG1179.USD","KVUE","LU0792757196.USD","LU0029864427.USD","LU0889566641.SGD","BK4585","LU1267930573.SGD","LU1267930813.SGD","BK4018","LU0128525929.USD","BK4588","RSPS","BK4567","LU0310800379.SGD","LU2463526074.USD","IE00B3T34201.USD","LU1585245621.USD","BK4504","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124875818","title":"南非竞争委员会建议:附条件批准金佰利与Kenvue Inc的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1124875818","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124875818?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:53","pubTimestamp":1780401216,"startTime":"0","endTime":"0","summary":"南非竞争委员会已向法庭提出建议,支持批准金佰利与Kenvue Inc之间的交易,但需满足特定条件。此举为两家公司的合作铺平了道路,同时确保了市场竞争的公平性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","IE00BFXG1179.USD","LU0128525929.USD","LU0792757196.USD","IE00B3T34201.USD","LU1430594728.SGD","LU0708994859.HKD","LU0029864427.USD","BK4504","BK4567","SG9999001440.SGD","KMB","LU1267930813.SGD","BK4585","LU0889566641.SGD","LU2463526074.USD","LU0310800379.SGD","KVUE","BK4018","LU1571399168.USD","LU1267930573.SGD","BK4183","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169354128","title":"Greyparrot与Kenvue携手,借AI材料回收智能加速循环包装进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1169354128","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169354128?lang=zh_cn&edition=full","pubTime":"2026-05-20 21:09","pubTimestamp":1779282584,"startTime":"0","endTime":"0","summary":"Greyparrot与Kenvue宣布合作,共同利用人工智能驱动的材料回收智能技术,以加速推进循环包装的实践与创新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4183","LU0029864427.USD","LU0708994859.HKD","LU0889566641.SGD","LU1267930573.SGD","LU1267930813.SGD","IE00BFXG1179.USD","LU0792757196.USD","KVUE","LU0310800379.SGD","IE00B3T34201.USD","BK4585","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136627544","title":"Kenvue在SEC文件中指出:中东冲突导致局势动态变化,预计宏观经济环境将持续波动","url":"https://stock-news.laohu8.com/highlight/detail?id=1136627544","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136627544?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:04","pubTimestamp":1778155494,"startTime":"0","endTime":"0","summary":"鉴于中东冲突引发的局势动态变化,Kenvue Inc (KVUE) 在提交给美国证券交易委员会(SEC)的文件中表示,预计宏观经济环境将保持持续波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","BK4588","KVUE","LU0310800379.SGD","BK4183","LU1267930813.SGD","LU0029864427.USD","LU0128525929.USD","LU0889566641.SGD","LU0708994859.HKD","BK4585","LU0792757196.USD","IE00BFXG1179.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188408986","title":"Kenvue Inc因与金佰利交易未决 暂停发布业绩前瞻指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1188408986","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188408986?lang=zh_cn&edition=full","pubTime":"2026-05-07 18:32","pubTimestamp":1778149932,"startTime":"0","endTime":"0","summary":"由于与金佰利公司的交易尚在推进中,Kenvue Inc决定暂不提供未来业绩展望指引。这一举措反映出公司在重大交易期间对市场预期保持审慎态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","KVUE","LU0029864427.USD","LU0708994859.HKD","LU0889566641.SGD","LU0310800379.SGD","LU0792757196.USD","IE00B3T34201.USD","BK4183","LU0128525929.USD","LU1267930813.SGD","BK4585","BK4588","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517922855","title":"加拿大投资银行集团:维持Kenvue(KVUE.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至29.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517922855","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517922855?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:32","pubTimestamp":1741210369,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Kenvue(KVUE.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至29.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06053248551376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509723731","title":"瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由23.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509723731","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509723731?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:06","pubTimestamp":1738944418,"startTime":"0","endTime":"0","summary":"瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由23.00美元调整至21.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08000648031213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196136077","title":"肯维公司第四季度调整后每股收益 $0.26 符合预期,销售额 $36.6 亿低于 $37.7 亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1196136077","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196136077?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:56","pubTimestamp":1738842968,"startTime":"0","endTime":"0","summary":"肯维公司发布季度调整后每股收益 $0.26,符合分析师一致预期。这比去年同期每股收益 $0.31 减少了 16.13%。公司报告季度销售额为 $36.6 亿,低于分析师一致预期的 $37.7 亿,相差 2.75%。相比去年同期的销售额 $36.7 亿,下降了 0.11%。以上内容来自Benzinga Earnings专栏,原文如下:Kenvue reported quarterly adjusted earnings of $0.26 per share which met the analyst consensus estimate. This is a 16.13 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $3.66 billion which missed the analyst consensus estimate of $3.77 billion by 2.75 percen","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"肯维公司第四季度调整后每股收益 $0.26 符合预期,销售额 $36.6 亿低于 $37.7 亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504940616","title":"瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由24.00美元调整至23.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504940616","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504940616?lang=zh_cn&edition=full","pubTime":"2025-01-17 04:41","pubTimestamp":1737060085,"startTime":"0","endTime":"0","summary":"瑞银:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由24.00美元调整至23.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/17044147536410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503675224","title":"花旗:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由25.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503675224","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503675224?lang=zh_cn&edition=full","pubTime":"2025-01-16 02:47","pubTimestamp":1736966842,"startTime":"0","endTime":"0","summary":"花旗:维持Kenvue(KVUE.US)评级,由中性调整至中性评级, 目标价由25.00美元调整至21.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/16024747498441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501045251","title":"Piper Sandler:上调Kenvue(KVUE.US)评级,由中性调整至增持评级, 目标价由21.00美元调整至26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501045251","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501045251?lang=zh_cn&edition=full","pubTime":"2025-01-07 00:12","pubTimestamp":1736179932,"startTime":"0","endTime":"0","summary":"Piper Sandler:上调Kenvue(KVUE.US)评级,由中性调整至增持评级, 目标价由21.00美元调整至26.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07001247180724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490724588","title":"顶级亿万富豪投资者的五笔股票买卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2490724588","media":"福布斯中文网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490724588?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:08","pubTimestamp":1733994480,"startTime":"0","endTime":"0","summary":"原文标题:《顶级亿万富豪投资者的五笔股票买卖》过去30个月里,我们构建了两个《福布斯》亿万富豪投资者模拟投资组合。在决定采取何种策略时,我们的主要参考因素之一就是亿万富豪投资者们公开的操作动向。《福布斯》观察了最富有的五位白手起家亿万富豪投资者的五笔最大买入和五笔最大卖出操作,得出25个有趣的洞察,巴菲特购入达美乐股份便是其一。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-12-12/doc-inczezhn9699146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["TEAM","SIRI","COP","T","AAPL","DPZ","FIX","FOXA","MDT","ESmain","VST","BRK.B","HEI","NVDA","CVX","03145","BMY","META","EQT","LYFT","BAC","KVUE","CMCSA","NRG","NVDY","MAR","PDD","EME","TLN","UPRO","COF","NVDD","CHTR","SPY","MSFT","EQIX","RCL","BRK.A"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2489110445","title":"Kenvue Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489110445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489110445?lang=zh_cn&edition=full","pubTime":"2024-12-05 02:05","pubTimestamp":1733335502,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日02时05分,Kenvue Inc.股票出现异动,股价大幅跳水5.00%。截至发稿,该股报22.31美元/股,成交量1062.01万股,换手率0.55%,振幅5.15%。Kenvue Inc.股票所在的个人用品行业中,整体涨幅为0.07%。Kenvue Inc.公司简介:Kenvue 是全球销售额最大的单一经营消费者健康的公司,年收入达 150 亿美元。Kenvue 前身为强生公司的消费者部门,于 2023 年 5 月分拆上市。尽管行业分散、竞争激烈、消费者偏好不断变化,但 Kenvue 的许多品牌凭借强大的品牌力成为各自细分市场的全球领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120502050298e565d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120502050298e565d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B3T34201.USD","BK4585","BK4183","KVUE","IE00BFXG1179.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kenvue.com;investors.kenvue.com","stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0313},{"period":"3month","weight":0.1094},{"period":"6month","weight":0.0026},{"period":"1year","weight":-0.0667},{"period":"ytd","weight":0.1113}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kenvue Inc.于2022年2月23日在特拉华州成立。该公司是全球最大的纯消费者健康公司。该公司寻求通过提供以消费者健康为中心的科学支持的创新产品、解决方案和体验,实现可持续的盈利增长。他们的业务遍及全球超过165个国家,并拥有超过135年的传统,在医疗保健和消费品的交叉点上处于全球领先地位。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.009959},{"month":2,"riseRate":0.666667,"avgChangeRate":0.040858},{"month":3,"riseRate":0.666667,"avgChangeRate":0.01575},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.040682},{"month":5,"riseRate":0.666667,"avgChangeRate":0.007562},{"month":6,"riseRate":0.5,"avgChangeRate":-0.005572},{"month":7,"riseRate":0.75,"avgChangeRate":-0.013872},{"month":8,"riseRate":0.25,"avgChangeRate":0.030709},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.097138},{"month":10,"riseRate":0,"avgChangeRate":-0.065652},{"month":11,"riseRate":1,"avgChangeRate":0.118818},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.021936}],"exchange":"NYSE","name":"Kenvue Inc","nameEN":"Kenvue Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kenvue Inc(KVUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kenvue Inc(KVUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kenvue Inc,KVUE,Kenvue Inc股票,Kenvue Inc股票老虎,Kenvue Inc股票老虎国际,Kenvue Inc行情,Kenvue Inc股票行情,Kenvue Inc股价,Kenvue Inc股市,Kenvue Inc股票价格,Kenvue Inc股票交易,Kenvue Inc股票购买,Kenvue Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kenvue Inc(KVUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kenvue Inc(KVUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}